UPDATE 2-Rite Aid taps healthcare executive as its new CEO

(Adds analyst comment, share movement)

Aug 12 (Reuters) - Rite Aid Corp on Monday named Heyward Donigan as chief executive officer, hoping to use her expertise in managing healthcare companies to stem sales declines at the drugstore chain due to intense competition.

Brick-and-mortar drug retailers have been hit as Americans are increasingly relying on online retailers such as Amazon.com to buy over-the-counter treatments and as more customers purchase low-cost generic drugs.

Last week, Walgreens Boots Alliance Inc said it plans to close about 200 stores in the United States as part of its cost management program aimed at mitigating the pressure related to generic drug prices.

Rite Aid sold more than 1,900 stores to Walgreens in 2018.

"Today's announcement is another illustration of the challenges that retail pharmacy is facing as Rite Aid has moved from a CEO with a retail background to one with experience in managed care/providers," Evercore ISI analyst Ross Muken said.

Donigan, who most recently served as CEO at Sapphire Digital, a website that analyzes health-care plans, will succeed John Standley, who has led the company since 2010.

She has also held executive roles at Cigna Corp, General Electric Co and U.S. Healthcare.

Muken expects Donigan to consider partnerships with other healthcare companies as the drugstore chain works to combat declining front-end sales and lower pharmacy profitability.

Shares of Rite Aid, which have fallen 49% so far this year, were up 1.7% at $7.31 before the bell.

"While investors may be temporarily encouraged by new management and its future plans, we are skeptical that much can be done besides putting off the day of reckoning," Muken added in a note.

Rite Aid in March announced a restructuring plan, including a change in leadership and a reduction of 400 corporate positions, aimed at saving about $55 million annually.

Last year, the company saw its $24 billion merger with U.S. grocer Albertsons Companies Inc fall through after its shareholders opposed the deal.

(Reporting by Saumya Sibi Joseph in Bengaluru; Editing by Shinjini Ganguli)


More Related News

Forget the delivery truck. Walgreens is delivering aspirin, snacks via drone
Forget the delivery truck. Walgreens is delivering aspirin, snacks via drone

Walgreens customers in Virginia will be able to get those items, and many more, dropped at their doorstep by drone.

Mark Hurd, Oracle CEO Who Led Three Tech Companies, Dies
Mark Hurd, Oracle CEO Who Led Three Tech Companies, Dies

(Bloomberg) -- Mark Hurd, who was chief executive officer of three major technology companies including Oracle Corp., has died. He was 62.Larry Ellison, Oracle's chairman, confirmed his passing in an online post."It is with a profound sense of sadness and loss that I tell everyone here at Oracle that

McKesson CEO Among Four Summoned to Court For Opioid Talks
McKesson CEO Among Four Summoned to Court For Opioid Talks

(Bloomberg) -- The CEOs of McKesson Corp., Cardinal Health Inc. and two other companies seeking to settle legal claims over their handling of opioid painkillers were summoned to meet with a judge in hopes of hammering out a final deal, according to two people familiar with the matter.U.S. District Judge Dan Polster in Cleveland, who is overseeing the first federal trial over the U.S. opioid epidemic, demanded that the chief executive officers appear in his court on Friday to discuss their settlement proposals, according to the people, who asked not to be identified because the negotiations are confidential.In a sign that talks may be entering their end-game, Polster made his demand on...

Ericsson's CEO Sees Dramatic Acceleration of Demand for 5G Technology

Oct.17 -- Borje Ekholm, chief executive officer at Ericsson, discusses the 5G market, Huawei, earnings and guidance for 2020. He speaks on "Bloomberg Markets: European Open."

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply


Top News: Economy

Hit "Like"
Don't miss any important news
Thanks, you don't need to show me this anymore.